Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Academic Radiology
|
January 10, 2015
Automated breast segmentation of fat and water MR images using dynamic programming
José A Rosado-Toro, Tomoe Barr, Jean-Philippe Galons, et al.
The British Journal of Surgery
|
March 13, 2026
Surgery for interplanetary space missions
Raghav Khanna, Yang Li, Matthew Cook, et al.
Molecular Cancer Therapeutics
|
July 5, 2021
Recombinant Newcastle Disease Virus Immunotherapy Drives Oncolytic Effects and Durable Systemic Antitumor Immunity
James Harper, Shannon Burke, Jon Travers, et al.
Scientific Reports
|
May 27, 2024
HER2 quantitative continuous scoring for accurate patient selection in HER2 negative trastuzumab deruxtecan treated breast cancer
Ansh Kapil, Andreas Spitzmüller, Nicolas Brieu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2022
Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA)
Alan L Ho, Marek Dedecjus, Lori J Wirth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2026
DESTINY-Breast08: a phase 1b study of trastuzumab deruxtecan in combination with other anticancer therapies in patients with HER2-low metastatic breast cancer
Komal Jhaveri, Sherene Loi, Erika Hamilton, et al.
JCO Precision Oncology
|
May 28, 2026
Human Epidermal Growth Factor Receptor 2 Quantification Using Computational Pathology to Identify Novel Biomarkers for Trastuzumab Deruxtecan-Treated Human Epidermal Growth Factor Receptor 2-Positive Gastric Cancer
Ansh Kapil, Henrik Failmezger, Yu Fu, et al.
Nature Medicine
|
May 4, 2021
An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer
Thomas Powles, Danielle Carroll, Simon Chowdhury, et al.
Molecular Cancer Therapeutics
|
March 31, 2021
Macrophage Activation Status Rather than Repolarization Is Associated with Enhanced Checkpoint Activity in Combination with PI3Kγ Inhibition
Larissa S Carnevalli, Molly A Taylor, Matthew King, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2020
A Randomized, Open-label, Presurgical, Window-of-Opportunity Study Comparing the Pharmacodynamic Effects of the Novel Oral SERD AZD9496 with Fulvestrant in Patients with Newly Diagnosed ER<sup>+</sup> HER2<sup>-</sup> Primary Breast Cancer
John F R Robertson, Abigail Evans, Stephan Henschen, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Academic Radiology
|
January 10, 2015
Automated breast segmentation of fat and water MR images using dynamic programming
José A Rosado-Toro, Tomoe Barr, Jean-Philippe Galons, et al.
The British Journal of Surgery
|
March 13, 2026
Surgery for interplanetary space missions
Raghav Khanna, Yang Li, Matthew Cook, et al.
Molecular Cancer Therapeutics
|
July 5, 2021
Recombinant Newcastle Disease Virus Immunotherapy Drives Oncolytic Effects and Durable Systemic Antitumor Immunity
James Harper, Shannon Burke, Jon Travers, et al.
Scientific Reports
|
May 27, 2024
HER2 quantitative continuous scoring for accurate patient selection in HER2 negative trastuzumab deruxtecan treated breast cancer
Ansh Kapil, Andreas Spitzmüller, Nicolas Brieu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2022
Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA)
Alan L Ho, Marek Dedecjus, Lori J Wirth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2026
DESTINY-Breast08: a phase 1b study of trastuzumab deruxtecan in combination with other anticancer therapies in patients with HER2-low metastatic breast cancer
Komal Jhaveri, Sherene Loi, Erika Hamilton, et al.
JCO Precision Oncology
|
May 28, 2026
Human Epidermal Growth Factor Receptor 2 Quantification Using Computational Pathology to Identify Novel Biomarkers for Trastuzumab Deruxtecan-Treated Human Epidermal Growth Factor Receptor 2-Positive Gastric Cancer
Ansh Kapil, Henrik Failmezger, Yu Fu, et al.
Nature Medicine
|
May 4, 2021
An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer
Thomas Powles, Danielle Carroll, Simon Chowdhury, et al.
Molecular Cancer Therapeutics
|
March 31, 2021
Macrophage Activation Status Rather than Repolarization Is Associated with Enhanced Checkpoint Activity in Combination with PI3Kγ Inhibition
Larissa S Carnevalli, Molly A Taylor, Matthew King, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2020
A Randomized, Open-label, Presurgical, Window-of-Opportunity Study Comparing the Pharmacodynamic Effects of the Novel Oral SERD AZD9496 with Fulvestrant in Patients with Newly Diagnosed ER<sup>+</sup> HER2<sup>-</sup> Primary Breast Cancer
John F R Robertson, Abigail Evans, Stephan Henschen, et al.
Page
of 3